WHO Approves Biannual HIV Prevention Injection

The World Health Organisation (WHO) has endorsed the global rollout of injectable lenacapavir, a groundbreaking HIV prevention drug administered just twice a year. Announced at the 13th International AIDS Society (IAS 2025) Conference in Kigali, Rwanda, the drug is seen as a game-changer for at-risk populations who struggle with daily oral medication. “Lenacapavir is the...